TY - JOUR
T1 - Effects of Exercise Training and Weight Loss on Plasma Fetuin-A Levels and Insulin Sensitivity in Overweight Older Men
AU - Blumenthal, Jacob B.
AU - Gitterman, Anna
AU - Ryan, Alice S.
AU - Prior, Steven J.
N1 - Funding Information:
This research was supported by a VA Advanced Research Career Development Award (Jacob B. Blumenthal), a VA Merit Review Award (Alice S. Ryan), NIH K01-AG-021457 (Lyndon J. Joseph), a Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (NIH K23-AG040775 and AFAR, Steven J. Prior), a VA Career Development Award (Steven J. Prior), a VA Senior Research Career Scientist Award (Alice S. Ryan), the University of Maryland Claude D. Pepper Center (NIH P30-AG028747), the Mid-Atlantic Nutrition Obesity Research Center (P30-DK072488), and the Baltimore Veterans Affairs Medical Center Geriatric Research, Education and Clinical Center (GRECC).
Publisher Copyright:
© 2017 Jacob B. Blumenthal et al.
PY - 2017
Y1 - 2017
N2 - Aerobic exercise training and weight loss (AEX+WL) improves insulin sensitivity in overweight adults; however, the underlying pathways are incompletely understood. Fetuin-A, a hepatokine that inhibits insulin signaling, may be involved in the salutary effects of AEX+WL. Therefore, we examined the effects of 6-month AEX+WL on plasma fetuin-A levels (36-48 hours after the last bout of exercise), aerobic capacity (VO2max), body composition, glucose tolerance, and insulin sensitivity (M) in 16 sedentary, overweight-obese older men (age = 60 ± 2 years, BMI = 31 ± 1 kg/m2) with no history of cardiovascular disease or diabetes. At baseline, fetuin-A levels correlated directly with adiposity and had a borderline inverse correlation with M. After AEX+WL, body weight decreased by 10 kg, while both VO2max and M increased by 16% (P<0.005 for all). Contrary to our hypothesis, plasma fetuin-A levels increased after AEX+WL (1.16 ± 0.10 g/L versus 1.70 ± 0.19 g/L, P=0.006). This increase was unrelated to changes in body composition or glucose metabolism, but directly correlated with changes in VO2max (r=0.57, P<0.05). Thus, in overweight-to-obese older men, AEX+WL appears to increase plasma fetuin-A levels. Although not associated with improvements in insulin sensitivity, this increase in fetuin-A was related to improvements in aerobic capacity and could be representative of the cardioprotective effects of AEX+WL in older men.
AB - Aerobic exercise training and weight loss (AEX+WL) improves insulin sensitivity in overweight adults; however, the underlying pathways are incompletely understood. Fetuin-A, a hepatokine that inhibits insulin signaling, may be involved in the salutary effects of AEX+WL. Therefore, we examined the effects of 6-month AEX+WL on plasma fetuin-A levels (36-48 hours after the last bout of exercise), aerobic capacity (VO2max), body composition, glucose tolerance, and insulin sensitivity (M) in 16 sedentary, overweight-obese older men (age = 60 ± 2 years, BMI = 31 ± 1 kg/m2) with no history of cardiovascular disease or diabetes. At baseline, fetuin-A levels correlated directly with adiposity and had a borderline inverse correlation with M. After AEX+WL, body weight decreased by 10 kg, while both VO2max and M increased by 16% (P<0.005 for all). Contrary to our hypothesis, plasma fetuin-A levels increased after AEX+WL (1.16 ± 0.10 g/L versus 1.70 ± 0.19 g/L, P=0.006). This increase was unrelated to changes in body composition or glucose metabolism, but directly correlated with changes in VO2max (r=0.57, P<0.05). Thus, in overweight-to-obese older men, AEX+WL appears to increase plasma fetuin-A levels. Although not associated with improvements in insulin sensitivity, this increase in fetuin-A was related to improvements in aerobic capacity and could be representative of the cardioprotective effects of AEX+WL in older men.
UR - http://www.scopus.com/inward/record.url?scp=85026525703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026525703&partnerID=8YFLogxK
U2 - 10.1155/2017/1492581
DO - 10.1155/2017/1492581
M3 - Article
C2 - 28770230
AN - SCOPUS:85026525703
SN - 2314-6745
VL - 2017
JO - Journal of diabetes research
JF - Journal of diabetes research
M1 - 1492581
ER -